GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 271 filers reported holding GUARDANT HEALTH INC in Q4 2019. The put-call ratio across all filers is 1.62 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $431,000 | -86.1% | 8,003 | -89.6% | 0.01% | -86.1% |
| Q2 2022 | $3,097,000 | -87.8% | 76,770 | -79.9% | 0.04% | -84.3% |
| Q1 2022 | $25,325,000 | -43.3% | 382,324 | -14.4% | 0.23% | -35.1% |
| Q4 2021 | $44,692,000 | +9.9% | 446,834 | +37.4% | 0.35% | +10.7% |
| Q3 2021 | $40,650,000 | -8.2% | 325,171 | -8.9% | 0.32% | -1.8% |
| Q2 2021 | $44,305,000 | -27.9% | 356,751 | -11.3% | 0.32% | -30.1% |
| Q1 2021 | $61,417,000 | +63.5% | 402,341 | +38.1% | 0.46% | +67.3% |
| Q4 2020 | $37,554,000 | -9.0% | 291,387 | -21.1% | 0.28% | -22.8% |
| Q3 2020 | $41,258,000 | +132.3% | 369,100 | +68.6% | 0.36% | +129.3% |
| Q2 2020 | $17,761,000 | +165.8% | 218,921 | +128.0% | 0.16% | +109.3% |
| Q1 2020 | $6,681,000 | +0.8% | 95,997 | +13.2% | 0.08% | +53.1% |
| Q4 2019 | $6,627,000 | +1362.9% | 84,812 | +1096.2% | 0.05% | +1125.0% |
| Q3 2019 | $453,000 | -64.0% | 7,090 | -51.4% | 0.00% | -60.0% |
| Q2 2019 | $1,260,000 | – | 14,598 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |